The World Health Organization's approval to give emergency use to the COVID-19 vaccine manufactured by China's Sinopharm has been welcomed by experts and health regulators worldwide.
On Friday, the WHO gave the vaccine the green light, paving the way for potentially millions of doses to be rolled out globally to reach countries in need and boost WHO-backed efforts such as the COVAX initiative.
COVAX is a global effort aimed at ensuring access in poorer nations to novel coronavirus vaccines.
The WHO is also considering approval for the emergency use of another Chinese vaccine made by Sinovac.
Andrea Taylor, an expert on global vaccine data at the Duke Global Health Institute, said two Chinese vaccines, if the Sinovac shot is included in the COVAX program, will constitute a "game changer".
"The situation right now is just so desperate for low- and lower-middle-income countries that any doses we can get out are worth mobilizing," Taylor told The New York Times. "Having potentially two options coming from China could really change the landscape of what's possible over the next few months."
Bangladesh is very pleased to learn about the WHO decision to include the Sinopharm vaccine in the emergency use listing, which surely comes as a big blessing for the whole world in the fight against the deadly disease, Mushtuq Hossain, an adviser at the Bangladesh Health Ministry's Institute of Epidemiology, Disease Control and Research, said in an interview with Xinhua News Agency.
"Our government has already signed an agreement with Chinese counterparts to import this vaccine," the health expert said.
Bangladesh's drug regulator has already approved the Sinopharm vaccine, Hossain said.
Speaking at the conference with South Asian foreign ministers that China hosted recently, he said that this was a good initiative by the Chinese government.
------------China Daily News